China’s humanoid robot sector logged over 200 equity financing events since the start of 2026, pulling in more than 30 billion yuan ($4.1B) in total — averaging roughly 330 million yuan ($45M) per day. This guide maps the key players and their strategies.
The Big Picture
China’s approach to humanoid robots differs fundamentally from the US:
- Government-backed: National and provincial subsidies, dedicated industrial zones
- Manufacturing-first: Focus on factory deployment before general-purpose applications
- Speed over perfection: Ship early, iterate fast, let data accumulate
- Price war: Aggressive pricing to capture market share
Tier 1: Production Scale
AgiBot (智元机器人)
Founded: 2023 | Funding: $1B+ | HQ: Shanghai
The clear leader in production volume. AgiBot shipped over 5,000 units from its Shanghai gigafactory by Q1 2026, primarily to automotive and electronics manufacturers.
Business model: Robot-as-a-Service at ~¥15,000/month ($2,000/month). This makes the economics work for factories — payback within 12-18 months compared to human labor costs.
Technology: In-house actuators, proprietary VLA model trained on factory manipulation data, edge inference on custom hardware.
Key advantage: Manufacturing execution. While competitors are still in pilot phase, AgiBot is running a production line shipping dozens of robots per week.
Unitree Robotics (宇树科技)
Founded: 2016 | Funding: $200M+ | HQ: Hangzhou
Unitree took the “Android of robots” approach — make it cheap, make it open, let the ecosystem build applications.
Product line:
- G1 ($16,000) — Entry-level humanoid for research
- H1 ($90,000) — Performance humanoid for advanced research and light commercial use
- Go2/B2 — Quadruped robots (their original product line, still major revenue)
Key advantage: Ecosystem. With 10,000+ robots shipped across all models, Unitree has the largest installed base of any Chinese robot company. The developer community drives application innovation.
UBTECH Robotics (优必选)
Founded: 2012 | Funding: Publicly traded (HKG: 9880) | HQ: Shenzhen
The oldest player, publicly traded since December 2023. Walker S series deployed in Foxconn and other electronics manufacturing facilities.
Key advantage: Public company resources and brand recognition. Long history in consumer and education robots provides a stable revenue base.
Tier 2: Scaling Up
Fourier Intelligence (傅利叶智能)
Focus: Rehabilitation and healthcare humanoids GR-2: Deployed in hospitals and rehabilitation centers Key advantage: Clear niche (medical) with less competition than factory automation
Galbot (加尔伯特)
Focus: Warehouse and logistics humanoids Funding: Over $100M raised in 2025-2026 Key advantage: Backed by logistics industry investors, direct access to deployment sites
Agilex Robotics (松灵机器人)
Focus: Mobile manipulation platforms Key advantage: Strong in AGV/AMR market, expanding to humanoid form factor
Tier 3: Emerging Players
| Company | Focus | Notable |
|---|---|---|
| Star Dynamics (星动纪元) | General-purpose humanoid | Tsinghua University spinoff |
| LimX Dynamics (逐际动力) | Bipedal locomotion | Best-in-class walking on rough terrain |
| Robot Era (开普勒) | Industrial humanoid | Focus on heavy manufacturing |
| EngineAI (众擎机器人) | Affordable humanoid | Targeting sub-$10K price point |
The Supply Chain
China’s humanoid robot supply chain is developing rapidly:
Actuators: Leadrive, Peak Robotics, Hiwonder — Chinese actuator makers are challenging established players like Harmonic Drive on price while approaching comparable performance.
Sensors: Hesai (LiDAR), Orbbec (depth cameras) — Domestic alternatives to Intel RealSense and Velodyne at 30-50% lower cost.
AI Chips: Horizon Robotics (Journey 6), Cambricon — Reducing dependence on NVIDIA for edge inference.
Simulation: Most Chinese companies still rely on NVIDIA Isaac Sim or MuJoCo. Domestic alternatives (like Tencent RoboticsX) are emerging but not yet competitive.
Government Policy
Key policy support for humanoid robots in China:
- National plan: Humanoid robots designated as a strategic technology in the 14th Five-Year Plan
- Provincial subsidies: Shanghai, Shenzhen, Beijing offer direct subsidies for humanoid robot R&D and production
- Industrial zones: Dedicated humanoid robot industrial parks in Shanghai (Pudong), Shenzhen, and Beijing
- Standards: China is pushing to define international standards for humanoid robots through ISO/TC 299
What to Watch
- AgiBot IPO: Widely expected in 2026-2027. Would be the first humanoid-focused IPO globally.
- Price war escalation: As more companies reach production, expect aggressive pricing that may consolidate the market.
- Export expansion: Chinese humanoid robots are starting to appear in Southeast Asian and Middle Eastern markets.
- VLA model development: China’s domestic VLA models (trained on Chinese factory data) may diverge from Western approaches.
Investment Takeaway
China’s humanoid robot ecosystem is 2-3 years behind the US in fundamental research but arguably ahead in manufacturing scale and cost optimization. The market is growing fast enough to support multiple winners, but consolidation is likely within 3-5 years as unit economics become the deciding factor.